Formula Growth’s RxSight RXST Stock Holding History

Formula Growth’s Portfolio RXST Stock Details RXST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-60,000	Closed	-$625K	–	153
2025 Q4	$625K	Buy	+60,000	New	+$602K	0.24%	111
2024 Q3	–	Sell	-40,870	Closed	-$2.46M	–	123
2024 Q2	$2.46M	Buy	+40,870	New	+$2.34M	0.89%	44

Other funds holding RXST

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

NSGL

No Street GP LP San Francisco, California $1.5B AUM 34.53% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Formula Growth's RXST Position: Q1 2026 in Review

Formula Growth sold out of RxSight (RXST) in Q1 2026, closing a stake of 60,000 shares — an estimated $625K sold.

Formula Growth first reported a position in RXST in Q2 2024 and held it in 2 quarters. The position peaked at $2.46M in Q2 2024. 164 funds tracked by Wall St. Rank hold RXST as of Q1 2026.

Formula Growth reported no remaining RxSight position as of Q1 2026 after selling out during the quarter.
Formula Growth sold 60,000 RxSight shares in Q1 2026, an estimated $625K.
Formula Growth first reported a position in RxSight in Q2 2024 and held it in 2 quarters.
Formula Growth's RxSight position peaked at $2.46M in Q2 2024.
164 funds tracked by Wall St. Rank held RxSight as of Q1 2026.

Based on Formula Growth's 13F filing for Q1 2026, filed 14 May 2026.